Header Logo

Connection

Erik Schadde to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Erik Schadde has written about Alemtuzumab.
Erik Schadde
Connection Strength
0.078
Alemtuzumab
  1. Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int. 2008 Jul; 21(7):625-36.
    View in: PubMed
    Score: 0.078
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.